# AbbVie and Genentech will become the 10th and 11th participants in the TrumpRx program.

*biotech · news · 2026-04-07 · Newsmax*

## Key points

- AbbVie and Genentech are the 10th and 11th companies to join the TrumpRx program.
- AbbVie will offer Humira at an 86% discount, reducing its price from $6,900 to about $950.
- Genentech will cut the price of Xofluza from $168 to about $50 for uninsured patients.
- The Trump administration is working to allow government insurance copays for TrumpRx drugs, pending congressional action.
- TrumpRx now offers over 61 discounted medications, up from about 40 at its February launch.

**Companies:** AbbVie, Genentech, Amgen
**Countries:** United States

[Read the full story on Newsmax](https://www.newsmax.com/finance/streettalk/trumprx-abbvie-genentech/2026/04/07/id/1252140/)

---

Canonical: https://newsio.io/n/220e46be-8f53-4ac2-9ded-078a714321bd/abbvie-and-genentech-will-become-the-10th-and-11th-participants-in-the-trumprx-p
Summarized by Newsio from Newsmax. https://newsio.io/how-it-works